BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15861320)

  • 1. The pro- and antiangiogenic effects of statins.
    Skaletz-Rorowski A; Kureishi Y; Shiojima I; Walsh K
    Semin Vasc Med; 2004 Nov; 4(4):395-400. PubMed ID: 15861320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy and angiogenesis.
    Skaletz-Rorowski A; Walsh K
    Curr Opin Lipidol; 2003 Dec; 14(6):599-603. PubMed ID: 14624137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW; Lefer DJ
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of statins on endothelium and endothelial progenitor cell recruitment.
    Walter DH; Dimmeler S; Zeiher AM
    Semin Vasc Med; 2004 Nov; 4(4):385-93. PubMed ID: 15861319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.
    Dimmeler S; Aicher A; Vasa M; Mildner-Rihm C; Adler K; Tiemann M; Rütten H; Fichtlscherer S; Martin H; Zeiher AM
    J Clin Invest; 2001 Aug; 108(3):391-7. PubMed ID: 11489932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and cardioprotection--more than just lipid lowering?
    Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse effects of statins on angiogenesis: new therapeutic avenues.
    Elewa HF; El-Remessy AB; Somanath PR; Fagan SC
    Pharmacotherapy; 2010 Feb; 30(2):169-76. PubMed ID: 20099991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HMG-CoA reductase pathway, statins and angioprevention.
    Feng C; Han A; Ye C; Xu R; Li M
    Semin Ophthalmol; 2006; 21(1):29-35. PubMed ID: 16517442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and the endothelium.
    Ii M; Losordo DW
    Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP; Walter MF; Jacob RF
    Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and angiogenesis: is it about connections?
    Khaidakov M; Wang W; Khan JA; Kang BY; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2009 Sep; 387(3):543-7. PubMed ID: 19615978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms.
    Merla R; Daher IN; Ye Y; Uretsky BF; Birnbaum Y
    Am Heart J; 2007 Aug; 154(2):391-402. PubMed ID: 17643594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and endothelial dysfunction.
    Larose E; Ganz P
    Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins activate AMP-activated protein kinase in vitro and in vivo.
    Sun W; Lee TS; Zhu M; Gu C; Wang Y; Zhu Y; Shyy JY
    Circulation; 2006 Dec; 114(24):2655-62. PubMed ID: 17116771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
    Kureishi Y; Luo Z; Shiojima I; Bialik A; Fulton D; Lefer DJ; Sessa WC; Walsh K
    Nat Med; 2000 Sep; 6(9):1004-10. PubMed ID: 10973320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells.
    Ludwig A; Friedel B; Metzkow S; Meiners S; Stangl V; Baumann G; Stangl K
    Biochem Pharmacol; 2005 Aug; 70(4):520-6. PubMed ID: 15996638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins, nitric oxide and neovascularization.
    Ma FX; Han ZC
    Cardiovasc Drug Rev; 2005; 23(4):281-92. PubMed ID: 16614729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.